National Music Centre Appoints Steve Kane as Board Chair Announces Governance Updates
GigaIPOs Reflect Structural Challenges in Public Markets Analysis Suggests
ADP Private Payrolls Surge Past Expectations in April Signaling Stable Labor Market
AnheuserBusch InBev Shares Edge Lower After Sales Miss Estimates
The Mandalorian and Grogu Opens to 82 Million Marking Disneys Lowest Star Wars Debut
US Advances AI Integration in Asia Following TrumpXi Meeting Senior Official Says
XOMAP Q1 2026 Earnings Preferred Stock Reports EPS Miss Amid Royalty Revenue Uncertainty
Kinsale Capital Group KNSL Q1 2026 Earnings Underwriting Strength Drives Another EPS Beat
PFSI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment
Stepan Company SCL Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises
STNE Q1 2026 Earnings EPS Misses Estimates by 391 Stock Edges Higher
BrightView Holdings Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Earnings Shortfall
Verizon VZ Holds Steady at 4834 as Consolidation Continues
Electronic Arts EA Holds Steady Near Midpoint as Investors Eye Key Levels
Eaton Vance TaxAdvantage Global Dividend Opp ETO Rises 1 Approaching Key Resistance Zone
Haverty Furniture HVT Sees Slight Decline Holds Near Support Levels
Franklin Universal Trust FT Edges Higher Amid Modest Trading Activity
Amazon Quanta Services and Monster Beverage Approach Potential Buy Zones as Market Momentum Shifts
NEUP Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency
Scinai Immunotherapeutics SCNI Extends Losses as Stock Hovers Near Key Support
CrossAmerica Partners CAPL Holds Steady With Modest Gain as Consolidation Continues
Kestra Medical Technologies KMTS Holds Steady Near Support Testing Resistance Levels
Star Equity Holdings STRR Edges Higher Key Levels and Momentum in Focus
Cambium Networks CMBM Hovers Near Support as Trading Volume Remains Subdued
Woodside Energy WDS Holds Steady Near 2175 Amid Mixed Energy Sector Sentiment
Nutex Health NUTX Surges 36 Key Levels and Technical Outlook
Bolt Biotherapeutics BOLT Slips 12 as Shares Test Key Support at 465